Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.62 USD | +2.81% | +5.94% | +36.64% |
21/05 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
20/05 | Immunome Completes Purchase of Antibodies From Atreca | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
852M | - | - | - | |||
118B | ||||||
106B | ||||||
23.4B | - | |||||
22.1B | - | |||||
18.34B |
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
- Sector Chart